Guided Therapeutics (GTHP) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Guided Therapeutics (GTHP) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -47.75% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 25.48% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 41.56% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 43.85% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 14.55% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -25.84% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 42.13% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 13.85% |
| 10 | Guided Therapeutics | 19.31 Mn | 19.30 Mn | - | 99.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.96% |
| Mar 31, 2026 | -118.79% |
| Dec 31, 2025 | -77.43% |
| Sep 30, 2025 | -13.44% |
| Jun 30, 2025 | -12.93% |
| Mar 31, 2025 | -4.99% |
| Dec 31, 2024 | -34.39% |
| Sep 30, 2024 | 13.10% |
| Jun 30, 2024 | 57.45% |
| Mar 31, 2024 | 59.02% |
| Dec 31, 2023 | -16,552.93% |
| Sep 30, 2023 | -47,961.69% |
| Jun 30, 2023 | -84,998.27% |
| Mar 31, 2023 | -38,435.80% |
| Dec 31, 2022 | -50.14% |
| Sep 30, 2022 | -696.13% |
| Jun 30, 2022 | 56.19% |
| Mar 31, 2022 | 99.88% |
| Dec 31, 2021 | -100.02% |
| Sep 30, 2021 | -100.00% |